CompletedPhase 1NCT03140813

An Initial Study of AZD7325 in Adults With Fragile X Syndrome

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital Medical Center, Cincinnati
Principal Investigator
Ernest Pedapati, MD
Cincinnati Chlidren's Hospital
Intervention
AZD7325 (High-Dose)(drug)
Enrollment
15 enrolled
Eligibility
18-50 years · All sexes
Timeline
20182020

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03140813 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome

← Back to all trials